Cite
ISG15-Induced IL-10 Is a Novel Anti-Inflammatory Myeloid Axis Disrupted during Active Tuberculosis
MLA
Brian J. Ferguson, et al. ISG15-Induced IL-10 Is a Novel Anti-Inflammatory Myeloid Axis Disrupted during Active Tuberculosis. Jan. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....27a9fc2767d4da3d952c647d894b6ef9&authtype=sso&custid=ns315887.
APA
Brian J. Ferguson, Daniel O. Patricio, Soraya Maria Menezes, Tim Dierckx, Murilo Delgobo, Daniel S. Mansur, Rodrigo Guabiraba, André Báfica, Johan Van Weyenbergh, & Paula Fernandes dos Santos. (2018). ISG15-Induced IL-10 Is a Novel Anti-Inflammatory Myeloid Axis Disrupted during Active Tuberculosis.
Chicago
Brian J. Ferguson, Daniel O. Patricio, Soraya Maria Menezes, Tim Dierckx, Murilo Delgobo, Daniel S. Mansur, Rodrigo Guabiraba, André Báfica, Johan Van Weyenbergh, and Paula Fernandes dos Santos. 2018. “ISG15-Induced IL-10 Is a Novel Anti-Inflammatory Myeloid Axis Disrupted during Active Tuberculosis,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....27a9fc2767d4da3d952c647d894b6ef9&authtype=sso&custid=ns315887.